Cargando…

Role of antibodies in vaccine-mediated protection against tuberculosis

Detalles Bibliográficos
Autores principales:	Dieli, Francesco, Ivanyi, Juraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991659/ https://www.ncbi.nlm.nih.gov/pubmed/35396489 http://dx.doi.org/10.1038/s41423-022-00861-6

Ejemplares similares

A booster with SARS-CoV-2 vaccines: protection against Omicron infection
por: Hu, Yuehong, et al.
Publicado: (2022)

A next‐generation vaccine for broader and long‐lasting COVID‐19 protection
por: Xi, Jinxiang, et al.
Publicado: (2022)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

COVID-19 and Tuberculosis
por: Yang, Heng, et al.
Publicado: (2020)

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?
por: Monteiro, Olivia
Publicado: (2022)

Switching salts to protect against cardiovascular disease
por: Abbott, Ben
Publicado: (2021)

The role of IL‐23 receptor signaling in inflammation‐mediated erosive autoimmune arthritis and bone remodeling
por: Razawy, Wida, et al.
Publicado: (2018)

Immunological consequences of strain variation within the Mycobacterium tuberculosis complex
por: Tientcheu, Leopold D., et al.
Publicado: (2017)

Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
por: Baumjohann, Dirk, et al.
Publicado: (2021)

Development of Antibody‐Directed Therapies: Quo Vadis?
por: Rodrigues, Tiago, et al.
Publicado: (2018)

Function and Potentials of M. tuberculosis Epitopes
por: Ivanyi, Juraj
Publicado: (2014)

Unraveling the Dynamics of Antibody-Antigen Interaction by DNA Origami
por: Nie, Zhou
Publicado: (2020)

A promising vaccine candidate against COVID-19
por: Wang, Xiwei, et al.
Publicado: (2020)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

Protecting against different subtypes of influenza viruses: a nanoparticle approach
por: Yi, Changhua, et al.
Publicado: (2020)

Protecting the blossoming brain – Neurocritical care in children
por: Häfner, Sophia Julia
Publicado: (2020)

SMIP-30, a potent and selective PPM1A inhibitor with potential to treat tuberculosis
por: Xu, Shujing, et al.
Publicado: (2022)

Auto-antibodies against type I IFNs are associated with severe COVID-19 pneumonia
por: Zhou, Weilin, et al.
Publicado: (2021)

The best protection is early detection: Fostering timely and accurate screening
por: Kattner, Aila Akosua
Publicado: (2021)

Boosting with variant-matched vaccines: an opportunity to win the race against Omicron
por: Wang, Jiayu, et al.
Publicado: (2022)

Mutated trimeric RBD vaccines: a platform against variants of concern
por: Aparicio, Belén, et al.
Publicado: (2023)

T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease
por: O'Connor, Richard A, et al.
Publicado: (2013)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

TT3.1: a journey to protect chloroplasts upon heat stress
por: Li, Jin-Yu, et al.
Publicado: (2022)

B cell engineering in vivo: Accelerating induction of broadly neutralizing antibodies against HIV-1 infection
por: Sun, Caijun, et al.
Publicado: (2023)

Microbial antibiotics take the lead in the fight against plant pathogens
por: Roca, Amalia, et al.
Publicado: (2022)

Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody
por: Li, Fang, et al.
Publicado: (2020)

Fighting the enemy: one health approach against microbial resistance
por: Udaondo, Zulema, et al.
Publicado: (2020)

Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
por: Provine, Nicholas M., et al.
Publicado: (2022)

Explorative probes and biomarkers, chronic Salmonella infections and future vaccines
por: Michán, Carmen, et al.
Publicado: (2012)

Granulation of m(1)A-modified mRNAs protects their functionality through cellular stress
por: Jiang, Hao
Publicado: (2020)

SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines
por: Li, Maochen, et al.
Publicado: (2022)

Real Nano “Light Vaccine” Will Benefit to COVID-19 Pandemic Control
por: Yang, Jianshe
Publicado: (2021)

New insights into pathogen-mediated modulation of host RNA splicing
por: Gao, Chuyun, et al.
Publicado: (2022)

PMEPA1 guards against TGF-β-mediated prostate cancer bone metastasis
por: Blee, Alexandra M., et al.
Publicado: (2016)

Plant Pollen Grains: A Move Towards Green Drug and Vaccine Delivery Systems
por: Iravani, Siavash, et al.
Publicado: (2021)

A good gut feeling on Sarm1-mediated axon degeneration
por: von Saucken, Victoria E., et al.
Publicado: (2021)

Struggling to get a universal meningococcal vaccine and novel uses for bacterial toxins in cancer treatment
por: Daniels, Craig, et al.
Publicado: (2010)

The dual role of ROS, antioxidants and autophagy in cancer
por: Walton, Emma Louise
Publicado: (2016)

Nanotube‐mediated plasmid transfer as a natural alternative for the improvement of industrially relevant bacteria
por: Molina‐Santiago, Carlos, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jtjjmp6iqv44815uckgih3qan6